PTEN公司
张力素
相扑蛋白
磷酸酶
PI3K/AKT/mTOR通路
细胞生物学
生物
磷酸化
抑癌基因
癌症研究
信号转导
分子生物学
基因
生物化学
癌变
泛素
作者
Benjamin D. Hopkins,Barry Fine,Nicole Steinbach,Meaghan Dendy,Zachary Rapp,Jacquelyn Shaw,Kyrie Pappas,Jennifer S. Yu,Cindy Hodakoski,Sarah M. Mense,Joshua U. Klein,Sarah Pegno,Maria Luisa Sulis,Hannah E. Goldstein,Benjamin Amendolara,Lei Liang,Matthew Maurer,Jeffrey N. Bruce,Peter Canoll,Hanina Hibshoosh
出处
期刊:Science
[American Association for the Advancement of Science]
日期:2013-06-07
卷期号:341 (6144): 399-402
被引量:297
标识
DOI:10.1126/science.1234907
摘要
Phosphatase and tensin homolog on chromosome ten (PTEN) is a tumor suppressor and an antagonist of the phosphoinositide-3 kinase (PI3K) pathway. We identified a 576-amino acid translational variant of PTEN, termed PTEN-Long, that arises from an alternative translation start site 519 base pairs upstream of the ATG initiation sequence, adding 173 N-terminal amino acids to the normal PTEN open reading frame. PTEN-Long is a membrane-permeable lipid phosphatase that is secreted from cells and can enter other cells. As an exogenous agent, PTEN-Long antagonized PI3K signaling and induced tumor cell death in vitro and in vivo. By providing a means to restore a functional tumor-suppressor protein to tumor cells, PTEN-Long may have therapeutic uses.
科研通智能强力驱动
Strongly Powered by AbleSci AI